Professional Documents
Culture Documents
iData Insights
Sepsis - Pipeline Review, H2 2015 Summary Global Markets Direct s,
Sepsis - Pipeline Review, H2 2015 ,
provides an overview of the Sepsis s therapeutic pipeline. This report provides comprehensive information on the
therapeutic development for Sepsis, complete with comparative analysis at various stages, therapeutics assessment
by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest
updates, and featured news and press releases. It also reviews key players involved in the therapeutic development
for Sepsis and special features on late-stage and discontinued projects. Global Markets Direct s report features
investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
built using data and information sourced from Global Markets Direct s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the
report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated
with the latest set of information. Additionally, processes including live news & deals tracking, browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive
advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-inclass products. Note*: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic
landscape of Sepsis - The report reviews key pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report
reviews key players involved in the therapeutics development for Sepsis and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects - A review of the Sepsis products under
development by companies and universities/research institutes based on information derived from company and
industry-specific sources - Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy
pipeline projects - Coverage of the Sepsis pipeline on the basis of target, MoA, route of administration and molecule
type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant
competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging
players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand
important and diverse types of therapeutics under development for Sepsis - Plan mergers and acquisitions effectively
by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by
understanding Sepsis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding
the factors that drove them from pipeline
Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landing-page.php?id=124189/sepsispipeline-review-h2-2015
To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landing-page.php?id=124189/sepsispipeline-review-h2-2015
Table of Contents
Table of Contents
2 List of Tables
6 List of Figures
7 Introduction
8 Global Markets Direct Report Coverage
8 Sepsis Overview
9 Therapeutics Development
165 Synthetic Peptides for Immunology and Infectious Diseases - Drug Profile
166 Synthetic Peptides for Infectious Disease - Drug Profile
167 Synthetic Peptides for Inflammation and Infectious Disorders - Drug Profile
168 Synthetic Peptides for Sepsis, Bacterial and Fungal Infections - Drug Profile
169 Synthetic Peptides to Inhibit LPS for Bacterial and Viral Infections - Drug Profile
170 TF-0003 - Drug Profile
171 thrombomodulin alfa - Drug Profile
172 TRX-306 - Drug Profile
174 vancomycin hydrochloride - Drug Profile
175 Yersinia pestis vaccine - Drug Profile
176 Sepsis - Recent Pipeline Updates
177 Sepsis - Dormant Projects
188 Sepsis - Discontinued Products
192 Sepsis - Product Development Milestones
193 Featured News & Press Releases
193 Appendix
198 Methodology
198 Coverage
198 Secondary Research
198 Primary Research
198 Expert Panel Validation
198 Contact Us
198 Disclaimer
Read More http://www.idatainsights.com/reports-landing-page.php?id=124189/sepsis-pipeline-review-h2-2015
About Us:
iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research
information aggregator and marketing research consulting firm. We conduct both primary and secondary research.
Our work does not end with research it is also involved in distributing reports for different companies . We provide
actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be
a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that
will make a difference to their bottom line.
Contact Us:
iData Insights
Tel: 1-866-237-2965
Web: http://www.idatainsights.com
Email: info@idatainsights.com